2.9 Hypoglycemia, Endocrine Tumors, Polyglandular Syndromes & Severe Hypertriglyceridemia
Key Takeaways
- Hypoglycemia not due to insulinoma, endocrine tumors, polyglandular autoimmune disorders and hypothalamic disorders are four separate named blueprint subsections.
- Whipple triad plus a plasma insulin, C-peptide and proinsulin panel drawn during hypoglycemia distinguishes insulinoma from sulfonylurea use and from surreptitious insulin injection.
- Exogenous insulin administration produces high insulin with suppressed C-peptide, whereas insulinoma and sulfonylurea both produce high insulin with high C-peptide.
- Carcinoid syndrome implies hepatic metastases or a bronchial primary, because gut-derived serotonin is otherwise cleared by first-pass hepatic metabolism.
- Chylomicronemia syndrome with triglycerides above roughly 1,000 mg/dL causes pancreatitis and is treated with fat restriction and fibrate therapy rather than with statins.
1. Evaluating Hypoglycemia in a Patient Without Diabetes
Hypoglycemia should be pursued only when Whipple triad is satisfied: symptoms consistent with hypoglycemia, a documented low plasma glucose at the time of symptoms, and relief of symptoms when glucose is raised. A capillary reading alone is insufficient.
The critical maneuver is drawing the diagnostic panel while the patient is hypoglycemic, before glucose is given. Once glucose is corrected the opportunity is gone.
| Cause | Insulin | C-peptide | Proinsulin | Sulfonylurea screen | Beta-hydroxybutyrate |
|---|---|---|---|---|---|
| Insulinoma | High | High | High | Negative | Low |
| Sulfonylurea / meglitinide | High | High | High | Positive | Low |
| Exogenous insulin | Very high | Suppressed | Low | Negative | Low |
| Non-islet tumor (IGF-2) | Low | Low | Low | Negative | Low |
| Fasting / alcohol / adrenal insufficiency | Low | Low | Low | Negative | High |
The single most testable discriminator is C-peptide. Endogenous insulin is secreted as proinsulin and cleaved, releasing equimolar C-peptide; pharmaceutical insulin contains none. High insulin with a suppressed C-peptide therefore means injected insulin — factitious or malicious administration — and the differential includes health care workers and relatives of people with diabetes. High insulin with a high C-peptide means the pancreas is secreting, and the sulfonylurea screen then separates a drug effect from an insulinoma.
Non-islet cell tumor hypoglycemia is caused by large mesenchymal or hepatic tumors secreting incompletely processed insulin-like growth factor 2, producing hypoglycemia with suppressed insulin and C-peptide.
Post-bariatric hypoglycemia is a late postprandial hyperinsulinemic hypoglycemia occurring one to three hours after eating, typically years after Roux-en-Y gastric bypass; it is managed with dietary modification rather than surgery.
2. Insulinoma
A usually small, usually benign, usually solitary pancreatic islet cell tumor causing fasting hypoglycemia. Confirmation classically uses a supervised 72-hour fast. Because the lesion is often under 2 cm, cross-sectional imaging may be negative and endoscopic ultrasound is more sensitive. About 10% are associated with multiple endocrine neoplasia type 1, so a young patient or one with a suggestive family history should be evaluated for coexisting hyperparathyroidism and pituitary disease. Treatment is surgical enucleation.
3. Carcinoid Syndrome
Neuroendocrine tumors secreting serotonin and other vasoactive mediators. The classic tetrad is episodic flushing, secretory diarrhea, wheezing and, late, right-sided valvular heart disease (tricuspid regurgitation and pulmonic stenosis).
The reasoning point that makes this a good exam item: a midgut carcinoid confined to the bowel does not cause the syndrome. Portal venous drainage delivers serotonin to the liver, which inactivates it on first pass. The syndrome therefore implies hepatic metastases — bypassing first-pass clearance — or a primary outside the portal system, such as a bronchial carcinoid. Right-sided valve involvement follows the same logic: the lungs inactivate the mediators before they reach the left heart.
Diagnosis uses 24-hour urinary 5-hydroxyindoleacetic acid, with dietary restriction of serotonin-rich foods beforehand. Somatostatin analogues control symptoms and slow progression. Carcinoid crisis — profound hypotension and bronchospasm precipitated by anesthesia or tumor manipulation — is treated with octreotide, not with catecholamines, which can worsen it.
4. Multiple Endocrine Neoplasia
| Syndrome | Components | Genetics |
|---|---|---|
| MEN 1 | Parathyroid hyperplasia, pancreatic islet tumors, pituitary adenoma (the "3 Ps") | MEN1 tumor suppressor |
| MEN 2A | Medullary thyroid carcinoma, pheochromocytoma, parathyroid hyperplasia | RET proto-oncogene |
| MEN 2B | Medullary thyroid carcinoma, pheochromocytoma, mucosal neuromas, marfanoid habitus | RET proto-oncogene |
Two management rules: in any MEN 2 patient undergoing surgery, pheochromocytoma must be excluded and treated first, because operating on an unblocked pheochromocytoma can precipitate a fatal hypertensive crisis. And in MEN 1, hyperparathyroidism is usually the earliest manifestation.
5. Polyglandular Autoimmune Syndromes
The blueprint names polyglandular autoimmune disorders with the subtopic multiple endocrine hypofunction. The exam concept is simple and high-yield: one autoimmune endocrinopathy predicts others.
| Syndrome | Core features | Notes |
|---|---|---|
| Type 1 (APECED) | Chronic mucocutaneous candidiasis, hypoparathyroidism, adrenal insufficiency | Childhood onset; AIRE mutation |
| Type 2 (Schmidt) | Adrenal insufficiency plus autoimmune thyroid disease and/or type 1 diabetes | Adult onset; far more common |
Associated conditions include pernicious anemia, celiac disease, vitiligo, alopecia areata and premature ovarian insufficiency.
The clinical trap: in a patient with known type 1 diabetes and autoimmune thyroid disease, a falling insulin requirement with unexplained hypoglycemia, fatigue, hyperkalemia and hyponatremia signals developing adrenal insufficiency, not improving diabetes. Similarly, starting levothyroxine in someone with unrecognized adrenal insufficiency can precipitate adrenal crisis by accelerating cortisol clearance — glucocorticoid replacement must come first.
6. Hypothalamic Disorders
A separately named blueprint subsection. Hypothalamic lesions — craniopharyngioma, germinoma, sarcoidosis, Langerhans cell histiocytosis, infiltrative disease, radiation — produce a distinctive combination that a purely pituitary lesion does not:
- Central diabetes insipidus (arginine vasopressin deficiency)
- Hyperprolactinemia from stalk effect — loss of dopaminergic inhibition, producing a modest prolactin elevation, in contrast to the marked elevation of a true prolactinoma
- Disordered thirst, temperature regulation, satiety and sleep-wake cycling
Marked hyperphagia with obesity, thermal dysregulation and adipsia points to the hypothalamus rather than the pituitary.
7. Chylomicronemia Syndrome
Listed under lipid disorders and separated from ordinary hypertriglyceridemia because both the risk and the treatment differ. Severe hypertriglyceridemia, generally above roughly 1,000 mg/dL, causes acute pancreatitis, and may produce eruptive xanthomas, lipemia retinalis and lipemic serum.
Familial chylomicronemia syndrome results from lipoprotein lipase pathway defects and presents in childhood. Far more commonly, adults have multifactorial chylomicronemia — an underlying genetic predisposition unmasked by uncontrolled diabetes, alcohol, obesity, hypothyroidism, pregnancy, estrogen therapy or a thiazide.
Management differs from routine lipid management in a way that is frequently tested:
- The target of therapy is pancreatitis prevention, not atherosclerotic risk reduction.
- Fibrates, not statins, are first-line; severe dietary fat restriction is essential; omega-3 fatty acids are adjunctive.
- Remove secondary contributors: control diabetes, stop alcohol, discontinue oral estrogen.
- In acute hypertriglyceridemic pancreatitis, insulin infusion and, in refractory cases, apheresis lower triglycerides rapidly.
- Artifact caution: severe lipemia interferes with laboratory assays and can produce spurious hyponatremia (pseudohyponatremia).
A 41-year-old operating-room nurse is admitted after a witnessed episode of confusion with a plasma glucose of 32 mg/dL that resolved with dextrose. Blood drawn during the episode shows a markedly elevated insulin level, a suppressed C-peptide level, and a negative sulfonylurea screen. What is the most likely explanation?
A 34-year-old man with poorly controlled type 2 diabetes and heavy alcohol use is admitted with acute pancreatitis. Triglycerides are 2,400 mg/dL and LDL cholesterol cannot be calculated. After acute management, which long-term strategy is most appropriate?